Works by Go, Ronald
Results: 223
T cell/histiocyte‐rich large B cell lymphoma: incidence, demographic disparities, and long‐term outcomes.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 140, doi. 10.1111/bjh.15391
- By:
- Publication type:
- Article
Financial Conflicts of Interest Among ASCO Annual Meeting Abstract Authors, Speakers, and Planners.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Re: Has Demand for Clinical Trial Participants Outpaced Supply?
- Published in:
- 2007
- By:
- Publication type:
- Letter
Activity of Nitazoxanide Against Viral Gastroenteritis: A Systematic Review.
- Published in:
- International Journal of Travel Medicine & Global Health, 2017, v. 5, n. 4, p. 107, doi. 10.15171/ijtmgh.2017.22
- By:
- Publication type:
- Article
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
- By:
- Publication type:
- Article
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00693-7
- By:
- Publication type:
- Article
Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00685-7
- By:
- Publication type:
- Article
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00632-6
- By:
- Publication type:
- Article
A simple additive staging system for newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00611-x
- By:
- Publication type:
- Article
Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00444-0
- By:
- Publication type:
- Article
Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00353-8
- By:
- Publication type:
- Article
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41408-020-00348-5
- By:
- Publication type:
- Article
A population-based study of chronic neutrophilic leukemia in the United States.
- Published in:
- 2020
- By:
- Publication type:
- Letter
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0319-0
- By:
- Publication type:
- Article
Venetoclax for the treatment of translocation (11;14) AL amyloidosis.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0298-1
- By:
- Publication type:
- Article
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0291-8
- By:
- Publication type:
- Article
The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-020-0275-8
- By:
- Publication type:
- Article
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.891712
- By:
- Publication type:
- Article
MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S435, doi. 10.1016/S2152-2650(21)01970-4
- By:
- Publication type:
- Article
TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S416, doi. 10.1016/S2152-2650(21)01935-2
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: MM-315: Impact of Stratification of Levels of Serum Lactate Dehydrogenase (LDH) at Diagnosis on Overall Survival (OS) in Newly Diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01605-0
- By:
- Publication type:
- Article
Poster: TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01560-3
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 451, doi. 10.1016/j.clml.2021.02.001
- By:
- Publication type:
- Article
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of bone marrow biopsy in patients with plasma cell disorders; should all patients with a monoclonal protein be biopsied?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e333, doi. 10.1016/j.clml.2019.09.547
- By:
- Publication type:
- Article
Venetoclax For The Treatment of Translocation AL Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e332, doi. 10.1016/j.clml.2019.09.546
- By:
- Publication type:
- Article
Impact of Minimal Residual Negativity on Outcomes in Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e331, doi. 10.1016/j.clml.2019.09.545
- By:
- Publication type:
- Article
Blood mass spectrometry Detects Residual Disease Better than Standard Techniques in Immunoglobulin light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e313, doi. 10.1016/j.clml.2019.09.514
- By:
- Publication type:
- Article
Pilot study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with POEMS Syndrome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e311, doi. 10.1016/j.clml.2019.09.512
- By:
- Publication type:
- Article
Venetoclax for the Treatment of Multiple Myeloma: Outcomes Outside of Clinical Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e278, doi. 10.1016/j.clml.2019.09.459
- By:
- Publication type:
- Article
Outcomes with different administration schedules of VRD as first-line therapy in multiple myeloma: a retrospective analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e203, doi. 10.1016/j.clml.2019.09.338
- By:
- Publication type:
- Article
A Hematopoietic Score Predicts Survival in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e85, doi. 10.1016/j.clml.2019.09.137
- By:
- Publication type:
- Article
Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Second Primary Malignancies in T-Cell Neoplasm Survivors: A United States Population-Based Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S272, doi. 10.1016/j.clml.2018.07.195
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predictors of Early Treatment Failure following initial therapy for Systemic Immunoglobulin Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e83, doi. 10.1016/j.clml.2017.03.150
- By:
- Publication type:
- Article
Bortezomib Versus Non-Bortezomib Based Initial Treatment for Transplant Ineligible Patients with Light Chain Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e140, doi. 10.1016/j.clml.2017.03.254
- By:
- Publication type:
- Article
Natural History of t(11;14) Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e20, doi. 10.1016/j.clml.2017.03.034
- By:
- Publication type:
- Article
Myelomatous Involvement of the Central Nervous System.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Polyclonal Localized Light Chain Amyloidosis-A Distinct Entity?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Systemic AL Amyloidosis Myopathy: Presentation, Diagnostic Pitfalls and Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S80, doi. 10.1016/j.clml.2016.07.113
- By:
- Publication type:
- Article
Clinical Features and Outcomes of Plasmacytoma: a National Cancer Database Study (2000 – 2011).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S81, doi. 10.1016/j.clml.2016.07.114
- By:
- Publication type:
- Article
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
- Published in:
- 2016
- By:
- Publication type:
- journal article